Navigation Links
New Jersey Nets Shoot Down Staph with High-Tech Defense
Date:9/12/2007

Team Facilities Treated with the Antimicrobial Protection of the

SportsAide(R) System from SportCoatings(TM)

EAST RUTHERFORD, N.J., Sept. 12 /PRNewswire/ -- The New Jersey Nets are the next team in the NBA scoring with the high-tech SportsAide(R) treatment to help protect their team facilities from antimicrobial contamination.

SportsAide is part of the Sports Antimicrobial System(R) (SAS), a powerful family of treatments that inhibit and minimize microbial contamination on all sports facilities, surfaces, and textiles. SAS is made up of SportsAide, TurfAide(TM), FabricAide(TM) and additional maintenance products.

"With SportsAide in our athletic facilities we are being proactive against the spread of potentially harmful bacteria. We are excited to apply this treatment and are eager to enjoy facilities risk-free from microbial contagion," says Ed Stefanski, New Jersey Nets General Manager.

The Nets join the Milwaukee Bucks, Miami Heat, and Washington Wizards in the growing roster of NBA teams protected by SportsAide. In the NFL the Cleveland Browns, Minnesota Vikings, Washington Redskins and Detroit Lions have adopted SAS, along with the Atlanta Thrashers from the NHL. Countless Universities and high schools nationwide have also sought the SAS technology to protect their facilities, equipment and fields of play.

"The need for proactive technologies like SAS has become a universal requirement across sports at all levels. We are thrilled to add the New Jersey Nets into the robust roster protected by the SportsAide system," said Craig Andrews, CEO of SportCoatings.

SAS is powered by the AEGIS Microbe Shield(R) technology, which has been safely used in consumer goods and medical applications for more than 30 years. Registered with the EPA, it imparts an invisible layer of antimicrobial protection that will not leach any chemicals or heavy metals into the environment and will not rub off onto a player's skin. SportCoatings is the first and only to bring this unique antimicrobial to the athletic industry.

Applied by electrostatic spray, the AEGIS Microbe Shield technology creates a fatal attraction for microbes. On a microscopic level, the solution bonds to the surface and creates a matrix of positively charged sword-shaped molecules. Since single celled microorganisms have a negatively charged cell membrane, the microbes are attracted into the antimicrobial where they are speared and electrocuted.

Clean Gear USA, partner of SportCoatings and sales agent of the SportsAide system to the New Jersey Nets, is the leading athletic equipment cleaner and repair service in the New York/New Jersey area. (http://www.cleangearusa.com)

SportCoatings partners with mPact Environmental solutions, of Fountain Inn, S.C., exclusive provider of the AEGIS Microbe Shield to the Building Aftercare market. (http://www.mPactUSA.com)

A division of the Coatings Specialist Group (CSG) of Rochester Hills, MI, SportCoatings is the world leader in sports coatings offering a wide array of products that enhance, restore and maintain synthetic sports surfaces. For more information about SportCoatings or the Sports Antimicrobial System, log on to http://www.csgsport.com or call 888-510-2847.


'/>"/>
SOURCE SportCoatings
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Vladeck to head the University of Medicine and Dentistry of New Jersey
2. New Jersey Decides to Support $500 M Stem Cell Research
3. HIV Tests to Be Made Mandatory for Pregnant Women, Infants in New Jersey
4. Diabetes, obesity rates shooting up
5. Spurt in hospital admissions following football shoot-outs
6. London: HIV Rates Shoot Up Amongst Drug Users
7. Bamboo Shoots Causes Botulism Outbreak
8. Suicide Attempts Shoot Up Among Alcoholics with Personality Disorder
9. Measles Rate Shoot Up among Nursery Children in Scotland
10. A sty in Actress Konkona Sharma Disrupts the Shooting of Bi- Lingual movie Sunglass
11. Virginia Tech. Shooter -Human Rights or Innocent Lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: